BLYDT-HANSEN, Ingrid; BECH, Michelle; JACKSON, Shannon. Emicizumab in Severe Hemophilia A: Clinical and Patient Determinants of Transition Within a Standardized Program. Journal of Hematology, [S. l.], v. 14, n. 5, p. 257–261, 2025. DOI: 10.14740/jh2113. Disponível em: https://jh.elmerpub.com/jh/article/view/2113.. Acesso em: 4 nov. 2025.